trial · primary record
ALS20
Beta-Thalassemia
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Neutrophil Engraftment |
| Registry ID | NCT06364774 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:37.001Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06364774
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.